4.2 Article

Novel insights on the DNA interaction of calicheamicin γ1I

Journal

BIOPOLYMERS
Volume 103, Issue 8, Pages 449-459

Publisher

WILEY
DOI: 10.1002/bip.22591

Keywords

calicheamicin g1I; DNA binding; DNA cleavage

Funding

  1. AIRC

Ask authors/readers for more resources

Calicheamicin (I)(1) (Cal) is a unique molecule in which a DNA binding motif (aryl-tetrasaccharide) is linked to a DNA cleaving moiety (calicheamicinone). The hallmark of this natural product rests in the impressive optimization of these two mechanisms leading to a drug that is extremely efficient in cleaving DNA at well-defined sites. However, the relative contributions of these two structurally distinct domains to the overall process have not been fully elucidated yet. Here, we used different experimental approaches to better dissect the role of the aryl-tetrasaccharide and the enediyne moieties in the DNA sequence selective binding step as well as the in the cleavage reaction. Our results highlight the remarkable cooperation of the two components in producing an amazing molecular machine. The herein presented molecular details of this concerted mechanism of action can be further applied to rationally design more druggable compounds. (c) 2014 Wiley Periodicals, Inc. Biopolymers 103: 449-459, 2015.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

SARS-CoV-2 3CLpro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376

Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi, Chengjin Ye, Matteo Pavan, Davide Bassani, Andre Volland, Claudia Ascher, Alexander Kurt Hermann Weiss, David Bante, Reuben S. Harris, Stefano Moro, Bernhard Rupp, Luis Martinez-Sobrido, Dorothee von Laer

Summary: Protease inhibitors are effective antiviral drugs, and Nirmatrelvir is the first protease inhibitor developed specifically against the SARS-CoV-2 protease 3CLpro. By using a chimeric vesicular stomatitis virus (VSV), researchers identified mutations that confer resistance to nirmatrelvir.

SCIENCE TRANSLATIONAL MEDICINE (2023)

Article Chemistry, Medicinal

Streptogramin A derivatives as mitochondrial translation inhibitors to suppress glioblastoma stem cell growth

Denise Sighel, Giulia Battistini, Emanuele Filiberto Rosatti, Jacopo Vigna, Matteo Pavan, Romina Belli, Daniele Peroni, Federica Alessandrini, Sara Longhi, Michael Pancher, Joanna Rorbach, Stefano Moro, Alessandro Quattrone, Ines Mancini

Summary: New therapeutic strategies are needed for glioblastoma treatment, with a focus on glioblastoma stem cells (GSCs). Inhibition of mitochondrial translation has been identified as a potential target for GSCs, and the combination of streptogramins B and A antibiotics has shown promise in vitro. This study used docking calculations to develop new streptogramin A derivatives and evaluated their ability to suppress GSC growth and inhibit mitochondrial translation. The fluorine derivatives of dalfopristin and virginiamycin M1 were found to be more potent and penetrate cells to a greater extent, suggesting their potential as antineoplastic agents.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Drugging the Undruggable Trypanosoma brucei Monothiol Glutaredoxin 1

Annagiulia Favaro, Giovanni Bolcato, Marcelo A. A. Comini, Stefano Moro, Massimo Bellanda, Mattia Sturlese

Summary: Researchers conducted two different screenings for the peculiar redox system of Trypanosoma brucei parasite and discovered a small molecule that binds at the glutathione binding site. This finding represents an important step in developing a new strategy to interfere with the Trypanosoma Brucei redox system, potentially shedding light on the perturbation of this biochemical machinery and offering novel therapeutic possibilities.

MOLECULES (2023)

Article Microbiology

Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy In Vivo

Marta Celegato, Mattia Sturlese, Vivian Vasconcelos Costa, Marta Trevisan, Angelica SamerLallo Dias, Ingredy Beatriz Souza Passos, Celso Martins Queiroz-Junior, Lorenzo Messa, Annagiulia Favaro, Stefano Moro, Mauro Martins Teixeira, Arianna Loregian, Beatrice Mercorelli

Summary: This study identifies two small molecules with pan-flavivirus antiviral potential through virtual screening of over 1 million compounds. The molecules inhibit the replication of dengue virus, Zika virus, and West Nile virus, and show efficacy in a mouse model of dengue.
Article Chemistry, Medicinal

Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors

Teresa Gianferrara, Matteo Pavan, Davide Bassani, Fabrizio Vincenzi, Silvia Pasquini, Giovanni Bolcato, Katia Varani, Giampiero Spalluto, Stephanie Federico, Stefano Moro

Summary: Traditionally, molecular recognition between adenosine receptors and their ligands has been thought to occur with a 1:1 stoichiometry. However, recent simulations suggest an alternative 2:1 binding stoichiometry. In this study, a bis-ribosyl adenosine derivative, BRA1, was synthesized and tested for its binding and activation abilities on adenosine receptors, with molecular modeling used to rationalize its activity.

CHEMMEDCHEM (2023)

Article Biochemistry & Molecular Biology

Targeting the I7L Protease: A Rational Design for Anti-Monkeypox Drugs?

Andrea Dodaro, Matteo Pavan, Stefano Moro

Summary: The latest outbreak of monkeypox virus in 2022 highlights the potential threat it poses to public health. Due to the lack of specific treatments, the monkeypox virus I7L protease has been identified as a potential target for the development of new drugs. Through computational modeling and virtual screening, 14 potential inhibitors of the monkeypox I7L protease have been identified.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal Adenocarcinoma

Daniela Carbone, Michele De Franco, Camilla Pecoraro, Davide Bassani, Matteo Pavan, Stella Cascioferro, Barbara Parrino, Girolamo Cirrincione, Stefano Dall'Acqua, Stefano Moro, Valentina Gandin, Patrizia Diana

Summary: A library of 3-amino-1,2,4-triazine derivatives was designed and synthesized, which showed potent and selective inhibition of PDK. These compounds proved to be effective in inducing cancer cell death, especially in human pancreatic KRAS mutated cancer cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics

Matteo Pavan, Stefano Moro

Summary: Since its outbreak in December 2019, the COVID-19 pandemic has caused a global crisis, with millions of deaths. The urgency of finding suitable drugs has highlighted the importance of computer simulations in drug design. This study provides an overview of the pandemic, discusses drug management efforts, and explores the role of computer-aided drug discovery techniques in facing present and future pandemics.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Medicinal

Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma

Daniela Carbone, Michele De Franco, Camilla Pecoraro, Davide Bassani, Matteo Pavan, Stella Cascioferro, Barbara Parrino, Girolamo Cirrincione, Stefano Dall'Acqua, Stefania Sut, Stefano Moro, Valentina Gandin, Patrizia Diana

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer type with poor prognosis and drug resistance. Cell metabolism alteration plays a key role in PDAC progression, leading to cell proliferation, invasion, and chemotherapy resistance. In this study, a new series of indolyl-7-azaindolyl triazine compounds were synthesized, inspired by marine bis-indolyl alkaloids. These compounds were found to inhibit the enzymatic activity of pyruvate dehydrogenase kinases (PDKs), with a high selectivity against KRAS-mutant PDAC. Molecular docking analysis and cell growth inhibition assays demonstrated the potential of these derivatives as therapeutic options for PDAC.

MARINE DRUGS (2023)

Review Biochemistry & Molecular Biology

Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies

Davide Bassani, Stefano Moro

Summary: The use of computational approaches in drug discovery, known as computer-aided drug design (CADD), has become a crucial component in pharmaceutical discovery pipelines. CADD techniques have significantly improved the efficiency of early discovery steps, facilitating the selection of appropriate compounds from a vast chemical space. Furthermore, CADD methods rationalize the biochemical and interactive processes at the molecular level, allowing for rational 3D design and optimization of chemical entities. This review provides an overview of CADD methods, highlighting their potential applications, benefits, limitations, and weaknesses in various scenarios of pharmaceutical and biological interest.

MOLECULES (2023)

Article Microbiology

The E2F4/p130 Repressor Complex Cooperates with Oncogenic?Np73a To Inhibit Gene Expression in Human Papillomavirus 38 E6/E7-Transformed Keratinocytes and in Cancer Cells

Valerio Taverniti, Hanna Krynska, Assunta Venuti, Marie-Laure Straub, Cecilia Sirand, Eugenie Lohmann, Maria Carmen Romero-Medina, Stefano Moro, Alexis Robitaille, Luc Negroni, Denise Martinez-Zapien, Murielle Masson, Massimo Tommasino, Katia Zanier

Summary: The study reveals a direct interaction between delta Np73 alpha and the E2F4/p130 complex, which is involved in cell cycle control. This interaction may result in the rewiring of the E2F4/p130 transcriptional program, leading to oncogenesis.

MSPHERE (2023)

Article Oncology

A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells

Chiara Bertagnin, Lorenzo Messa, Matteo Pavan, Marta Celegato, Mattia Sturlese, Beatrice Mercorelli, Stefano Moro, Arianna Loregian

Summary: HPV-induced cancers are a major global health issue and lack specific therapeutic regimens. In this study, researchers identified a compound that could inhibit the interaction between the E7 protein and PTPN14, leading to a reduction in viability, proliferation, migration, and cancer-stem cell potential of HPV-positive cervical cancer cells. This compound also showed activity against cervical cancer cells transformed by different high-risk HPV genotypes, suggesting a potential broad-spectrum activity.

CANCER LETTERS (2023)

Article Chemistry, Medicinal

Fighting Antimicrobial Resistance: Insights on How the Staphylococcus aureus NorA Efflux Pump Recognizes 2-Phenylquinoline Inhibitors by Supervised Molecular Dynamics (SuMD) and Molecular Docking Simulations

Deborah Palazzotti, Tommaso Felicetti, Stefano Sabatini, Stefano Moro, Maria Letizia Barreca, Mattia Sturlese, Andrea Astolfi

Summary: The superbug Staphylococcus aureus (S.aureus) exhibits various resistance mechanisms, such as efflux pumps, which greatly contribute to antimicrobial resistance. The NorA efflux pump activity is particularly associated with S. aureus resistance to fluoroquinolone antibiotics (e.g., ciprofloxacin) by actively extruding them from cells. Efflux pump inhibitors (EPIs) can increase antibiotic concentrations in bacteria and restore their susceptibility, offering a promising strategy against bacterial resistance. The recent release of NorA efflux pump cryo-electron microscopy (cryo-EM) structures in complex with synthetic antigen-binding fragments (Fabs) represents a significant breakthrough in studying S. aureus antibiotic resistance. Combined molecular dynamics and docking experiments were used to investigate the molecular mechanisms behind the interaction between NorA and EPIs, aiming to elucidate how the NorA efflux pump recognizes its inhibitors. The findings provide insights into the dynamic NorA-EPI interactions and lay the foundation for future drug discovery efforts to combat antimicrobial resistance.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2023)

Correction Biochemistry & Molecular Biology

Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies (vol 28, 3906, 2023)

Davide Bassani, Stefano Moro

MOLECULES (2023)

Article Biochemistry & Molecular Biology

Pyrazolo-triazolo-pyrimidine Scaffold as a Molecular Passepartout for the Pan-Recognition of Human Adenosine Receptors

Veronica Salmaso, Margherita Persico, Tatiana Da Ros, Giampiero Spalluto, Sonja Kachler, Karl-Norbert Klotz, Stefano Moro, Stephanie Federico

Summary: This study investigates the structural features of ligands leading to affinity and/or selectivity at adenosine receptors. The findings suggest that bulky acyl moieties at position N5 and small alkyl groups at position N8 are associated with affinity and selectivity at the A(3) receptor. Meanwhile, a free amino function at the 5 position induces high affinity at the A(2A) and A(1) receptors.

BIOMOLECULES (2023)

No Data Available